Shuhuan Wu

417 citations
8 papers · 162 indexed · h-index 5
Topics
Hepatitis B Virus Studies (3 papers)Hepatitis C virus research (3 papers)Cancer-related molecular mechanisms research (2 papers)
Journals
SHILAP Revista de lepidopterologíaClinical Infectious DiseasesInternational Journal of Nanomedicine
Partner nations
ChinaTaiwanHong Kong

In The Last Decade

Shuhuan Wu

8 papers receiving 160 citations

Peers

Shuhuan Wu
Comparison fields: 5 of 48
  • Epidemiology 75
  • Hepatology 65
  • Molecular Biology 55
  • Cancer Research 30
  • Oncology 14
Replace Victoria Kegel with:
Victoria Kegel Germany
Georgia Günther Germany
Taihua Yang China
Eun Uk Jung South Korea
Yahui Liu China
Hongxin Piao China
Ghazaleh Pourali Iran
Gloria Álvarez‐Sola Spain
Lionel Leck Australia
Shuhuan Wu relative to Victoria Kegel Germany Victoria Kegel's profile →
Citations per field
00.5×1.5×
Victoria Kegel · 1×
Citations per year

Countries citing papers authored by Shuhuan Wu

Since Specialization
Citations

This map shows the geographic impact of Shuhuan Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuhuan Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuhuan Wu more than expected).

Fields of papers citing papers by Shuhuan Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuhuan Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuhuan Wu. The network helps show where Shuhuan Wu may publish in the future.

Co-authorship network of co-authors of Shuhuan Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Shuhuan Wu. A scholar is included among the top collaborators of Shuhuan Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuhuan Wu. Shuhuan Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
#WorkIndexed citations
1 17
2 4
3 23
4 41
5 11
6
Hepatitis C virus (HCV) genotype 2a has a better virologic response to antiviral therapy than HCV genotype 1b.
3
7 61
8 2

About Shuhuan Wu

Shuhuan Wu is a scholar working on Hepatology, Molecular Medicine and Cancer Research, having authored 8 papers that have together received 162 indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (3 papers), Hepatitis C virus research (3 papers) and Cancer-related molecular mechanisms research (2 papers). The work is most often cited by research in Hepatology (65 citations), Epidemiology (75 citations) and Cancer Research (30 citations). Shuhuan Wu has collaborated with scholars based in China, Taiwan and Hong Kong. Frequent co-authors include Hongyu Zhang, Huijuan Zhou, Qing Xie, Yingying Zhang, Chengwei Chen, Xue–Fan Bai, Henry Lik‐Yuen Chan, Jifang Sheng, Jianjie Chen and Hongxia Liang. Their work appears in journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and International Journal of Nanomedicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026